← Back to patent-cliff list
帕罗西汀/阿普唑仑
Tier C — Watch / tradeParoxetine/Alprazolam
梯瓦
Originator
2012
First approval
-
Expiry (public)
No sales data
Peak sales
化学药
Type
Targets：GABAAR、SERT
Brand：Aipratex
Indications (approved)：焦虑、抑郁
Regional status
US
-
EU
-
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Paroxetine/Alprazolam?
Approved indications include: 焦虑, 抑郁.
When does the Paroxetine/Alprazolam patent expire?
No public expiry year is available for Paroxetine/Alprazolam yet; this page updates once verified.
How do I get a quote for Paroxetine/Alprazolam intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-24